Pro: Impossible to successfully time the market


May 10, 2016

John Buckingham appeared on CNBC on May 10, 2016. John likes biotech stocks like Gilead and Amgen because they are trading at attractive valuations. If Hillary comes to power we will see what happens with the possibility of price controls and increased regulation. John already owns a sufficient amount of Apple, but if he didn’t, he would be a buyer today (May 10, 2016).

buckingham_cnbc_05102016

 

 

 

 

 

Click here to view the video.

MENU